Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,388 | -18,639 | -4,590 | -1,713 | -6,845 |
| Accounts receivable | 7 | 7 | 7 | 7 | 39 |
| Accounts payable and accrued liabilities | -128 | 270 | 529 | 368 | 87 |
| Other Working Capital | -1,106 | -2,999 | 298 | 305 | 100 |
| Other Operating Activity | 10,007 | 9,033 | 671 | 595 | 3,477 |
| Operating Cash Flow | $-17,608 | $-12,328 | $-3,085 | $-438 | $-3,142 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,366 | 5,584 | 0 | N/A | N/A |
| PPE Investments | 695 | 482 | N/A | N/A | N/A |
| Net Acquisitions | 5,849 | 5,849 | N/A | N/A | N/A |
| Other Investing Activity | 83 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $21,993 | $11,915 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,500 | 8,500 | 6,875 | 750 | 3,300 |
| Common Stock Issued | 5,954 | 0 | 0 | N/A | 0 |
| Financing Cash Flow | $14,454 | $8,500 | $6,875 | $750 | $3,300 |
| Beginning Cash Position | 306 | 306 | 306 | 306 | 148 |
| End Cash Position | 19,145 | 8,393 | 4,096 | 618 | 306 |
| Net Cash Flow | $18,839 | $8,087 | $3,790 | $312 | $158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,608 | -12,328 | -3,085 | -438 | -3,142 |
| Capital Expenditure | -3 | -1 | 0 | N/A | N/A |
| Free Cash Flow | -17,611 | -12,329 | -3,085 | -438 | -3,142 |